Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise

AIMS: To evaluate the efficacy and safety of evogliptin, a newly developed dipeptidyl peptidase‐4 inhibitor, in patients with type 2 diabetes (T2D) inadequately controlled by diet and exercise. MATERIALS AND METHODS: In this randomized, double‐blind, placebo‐controlled, parallel‐group, multicentre,...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Juri, Park, Sung Woo, Yoon, Kun Ho, Kim, Sung Rae, Ahn, Kyu Jeung, Lee, Jae Hyuk, Mok, Ji Oh, Chung, Choon Hee, Han, Kyung Ah, Koh, Gwan Pyo, Kang, Jun Goo, Lee, Chang Beom, Kim, Seong Hwan, Kwon, Na Young, Kim, Doo Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697645/
https://www.ncbi.nlm.nih.gov/pubmed/28448688
http://dx.doi.org/10.1111/dom.12987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697645/
https://www.ncbi.nlm.nih.gov/pubmed/28448688
http://dx.doi.org/10.1111/dom.12987

Ejemplares similares